Malawi

Disease outbreaks reported: Plague in Malawi

Format
Situation Report
Source
Posted
Originally published
As of 27 May 2002, the Malawian Ministry of Health has reported a total of 71 cases of bubonic plague in the district of Nsanje since the onset of the outbreak on 16 April 2002. The outbreak has so far affected 26 villages, 23 in the Ndamera area, 2 in Chimombo and 1 village in neighbouring Mozambique.
There is good cross border collaboration between Malawian and Mozambican health teams. WHO is assisting the Malawian Ministry of Health surveillance unit and the Nsanje district health staff in their efforts to contain the outbreak by providing supplies and technical support, including the training of health workers.

For more information about plague, see WHO Fact Sheet (below) and for the WHO publication, Plague Manual: Epidemiology, Distribution, Surveillance and Control.

* * *

Fact Sheet No. 267
January 2002

PLAGUE

Overview

Plague is primarily a disease of rodents which can affect humans. It is transmitted between rodents by rodent fleas and can be transmitted to people through infected rodent flea bites. It can also be transmitted to humans through direct contact with infected animal tissue. As with many primarily zoonotic diseases, where the disease is transmitted from vertebrae animals to humans, plague is a very severe disease in people, with a case-fatality ratio of 50%-60% if left untreated.

There are three main forms of plague in humans: bubonic, septicaemic and pneumonic.

  • Bubonic plague is the result of an insect bite in which the plague bacillus travels through the lymphatic system to the nearest lymph node. The lymph node then becomes inflamed and is followed by bubo formation, a reaction in the body which occurs following the entrance of Yersinia pestis, the plague bacillus, through the skin and in the lymph nodes;

  • The septicaemic form of plague occurs when infection spreads directly through the bloodstream. This form is usually fatal in the absence of antibiotic therapy;

  • Pneumonic plague is an infection of the lungs caused by the plague bacillus and also has a very high case-fatality ratio.
Plague is endemic in many countries in Africa, the Americas and Asia. In 1999, 14 countries reported 2,603 cases to WHO (including 212 deaths). These figures are comparable with the annual average figures (2,547 cases, 181 deaths) for the previous 10 years (1988-1997). Over the past decade, 76.2% of the cases and 81.8% of the deaths were reported from Africa.

Treatment: Effective treatment methods enable almost all plague patients to be cured if diagnosed in time. These methods include antibiotics and supportive therapy.

Prevention: The objective of preventive measures is to reduce the likelihood of people being bitten by infected fleas, of having direct contact with infective tissues, or of being exposed to patients with pneumonic plague. Important preventive measures include the following:

Case recognition and medical intervention:

  • Ensure dissemination of information concerning clinical features and case definition to health workers;

  • Verify that patients have been placed on appropriate antibiotic treatment and that local supplies of antibiotics are adequate to handle further cases;

  • Isolate pneumonic plague patients.
Vaccination: Plague vaccines are available worldwide, but are not recommended for immediate protection in outbreak situations. Vaccination is only recommended for high-risk groups, e.g. health workers and laboratory personnel who are constantly exposed to the risk of contamination.

Epidemiological and epizootical investigation and emergency control:

  • Identify the rodent and flea species most likely to be sources of infection in the area where the human case(s) was exposed;

  • Identify areas of potential risk to humans.
Surveillance and control
  • Conduct research to identify which local rodent and flea species should be targeted for extensive surveillance and control;

  • In endemic areas, long-term surveillance of zoonotic foci may be valuable. Management of plague foci comprises long term surveillance and control. Long-term environmental management is also strongly encouraged. This focuses on the elimination or reduction of areas in workplaces or near homes that are attractive to plague-susceptible rodents.
The use of these measures has led to a sharp reduction in human plague throughout the world. Today the distribution of plague coincides with the geographical distribution of its natural foci in some countries in Africa (e.g. Uganda, Madagascar, Democratic Republic of the Congo, United Republic of Tanzania) and Latin America.

For further information, journalists can contact Office of the Spokesperson, WHO, Geneva. Telephone (+41 22) 791 2599; Fax (+41 22) 791 4858; Email: inf@who.int All WHO Press Releases, Fact Sheets and Features as well as other information on this subject can be obtained on Internet on the WHO home page http://www.who.int/.

=A9 WHO/OMS, 2002